The first annual David Y. Gin Memorial Symposium will be held on Tuesday, April 30, 2013. Learn more »
David Y. Gin (1967-2011)
The staff at Memorial Sloan-Kettering Cancer Center note with sadness the untimely death of our esteemed colleague David Y. Gin, a brilliant and talented chemist who joined the Sloan-Kettering Institute in 2006. He was a gentle, kind, good-humored, and remarkable human being who will be sorely missed. We extend our deepest sympathies to David's family and friends.
For Research-Related Questions
If you have any questions related to Dr. Gin's laboratory, please contact Danielle Rose at firstname.lastname@example.org or 646-888-2554.
The goal of our research program involves the chemical synthesis of complex natural products of importance in biology and human medicine. At the core of this research program is the development of new synthetic strategies and methods guided by the study of chemical reactivity and mechanism. A major emphasis involves the efficient synthesis of complex oligosaccharides and glycoconjugates that are of value as immunostimulants in therapeutic and prophylactic vaccines. We have developed a series of new methods for oligosaccharide construction allowing for the synthesis of complex saponin adjuvants and subunit antigen glycopeptide constructs, whose potential for anti-cancer and anti-viral vaccine therapies are being investigated. We are also engaged in the synthesis of complex anti-tumor and anti-viral alkaloids, enabled by the development of novel heterocyle annulation strategies.
The development of novel hetero-cycloaddition reactions and nitrogen-transfer processes will play a key role in the synthesis of several polycyclic guanidine and pyrrolidine bioactive target molecules. These efforts will facilitate their use as biochemical probes and therapeutic agents, as well as allow for the generation of non-natural analogues for novel drug discovery.